TAO Synergies TAOX
NASDAQ TAOX
$4.14 +0.13 (+3.24%)
As of: Sep 9, 2026 · 11:58 AM EDT

TAO Synergies (TAOX) Operating Income (2024 - 2026)

TAO Synergies' (TAOX) quarterly Operating Income came in at -$1.6 million in Q2 2026, up 48.31% on a YoY basis from -$1.1 million in Q2 2025, and down 19.08% quarter-over-quarter from -$1.3 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Operating Income (2024 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Operating Income for 3 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Income rose 48.31% year-over-year to -$1.6 million; the trailing twelve-month figure through Jun 2026 stood at -$7.8 million (down 2.43% YoY), and the FY2025 full-year result was -$9.0 million, down 32.84% from the prior year.
  • Operating Income retreated to -$1.6 million in Q2 2026 per TAOX's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, Operating Income topped out at -$1.1 million in Q1 2025 and bottomed at -$3.1 million in Q4 2025.
  • Historically, Operating Income has averaged -$1.9 million across 3 years, with a median of -$1.6 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Operating Income tumbled 101.42% in 2025, then soared 48.31% in 2026.
  • Over 3 years, Operating Income stood at -$1.6 million in 2024, then sank by 101.42% to -$3.1 million in 2025, then surged by 50.07% to -$1.6 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$1.6 million, -$1.3 million, and -$3.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Amgen 212.20 Bn 198.21 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 181.83 Bn 178.65 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 132.47 Bn 124.61 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.56 Bn 74.56 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 61.59 Bn 56.40 Bn 1.37 Bn 493.00 Mn
6 Moderna 54.65 Bn 49.51 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.42 Bn 30.13 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 30.21 Bn 30.21 Bn 1.16 Mn -365.99 Mn
10 TAO Synergies 30.56 Mn 30.56 Mn - -1.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.57 Mn
Mar 31, 2026 -1.32 Mn
Dec 31, 2025 -3.14 Mn
Sep 30, 2025 -1.80 Mn
Jun 30, 2025 -3.04 Mn
Mar 31, 2025 -1.07 Mn
Dec 31, 2024 -1.56 Mn
Sep 30, 2024 -1.98 Mn
Jun 30, 2024 -1.58 Mn